You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

New Concepts in PAH: Treating to Achieve Low-Risk Status

  • Authors: Sonja D. Bartolome, MD; Oksana A. Shlobin, MD
  • CME / ABIM MOC Released: 3/31/2020
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 3/31/2021
Start Activity


Target Audience and Goal Statement

This activity is intended for cardiologists, pulmonologists and rheumatologists.

The goal of this activity is to address the importance of low-risk parameters in patients with pulmonary arterial hypertension (PAH), including strategies to achieve low-risk status in these patients to improve mortality outcomes.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical data supporting the low-risk use parameters in PAH
  • Have greater competence related to
    • The use of appropriate strategies to achieve low-risk status in patients with PAH


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Sonja D. Bartolome, MD

    Associate Professor and Associate Director
    Pulmonary Hypertension Program
    UT Southwestern
    Dallas, Texas

    Disclosures

    Disclosure: Sonja D. Bartolome, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Actelion; Bayer
    Received grants for clinical research from: Complexa; Pfizer; PhaseBio; United Therapeutics

  • Oksana A. Shlobin, MD

    Director
    Pulmonary Hypertension Program
    Inova Fairfax Hospital
    Falls Church, Virginia

    Disclosures

    Disclosure: Oksana A. Shlobin, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Bayer; Johnson & Johnson; United Therapeutics
    Served as a speaker or a member of a speakers bureau for: Bayer; Johnson & Johnson; United Therapeutics

Steering Committee

  • Sonja D. Bartolome, MD

    As listed above

  • Raymond L. Benza, MD

    Professor of Medicine
    Temple University School of Medicine
    Philadelphia, Pennsylvania
    Program Director, Advanced Heart Failure Transplantation, Mechanical Circulatory Support and Pulmonary Vascular Diseases
    Allegheny Health Network
    Pittsburgh, Pennsylvania, United States

    Disclosures

    Disclosure: Raymond L. Benza, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Abbott Laboratories
    Received grants for clinical research from: Abbott Laboratories; Actelion Pharmaceuticals, Ltd; Bayer HealthCare; Liquidia; Phase Bio; United Therapeutics Corporation

  • Sean P. Gaine, MD, PhD, FRCPI

    Professor
    Mater Misericordiae University Hospital
    University College Dublin
    Dublin, Ireland

    Disclosures

    Disclosure: Sean P. Gaine, MD, PhD, FRCPI, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Actelion Pharmaceuticals, Ltd; United Therapeutics Corporation
    Served as a speaker or a member of a speakers bureau for: Actelion Pharmaceuticals

  • Hossein Ardeschir Ghofrani, MD

    Professor of Pulmonary Vascular Medicine
    Medical Executive Director
    Kerckhoff-Klinik GmbH, Bad Nauheim
    Hesse, Germany

    Disclosures

    Disclosure: Hossein Ardeschir Ghofrani, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare; Gossamer; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; MSD
    Served as a speaker or a member of a speakers bureau for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare; MSD
    Received grants for clinical research from: Actelion Pharmaceuticals, Ltd; Bayer HealthCare

  • Joanna Pepke-Zaba, PhD, FRCP

    Consultant Respiratory Physician
    Director, National Pulmonary Vascular Disease Unit
    Royal Papworth Hospital
    NHS Foundation Trust
    Cambridge, United Kingdom

    Disclosures

    Disclosure: Joanna Pepke-Zaba, PhD, FRCP, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare; Merck & Co., Inc.
    Served as a speaker or a member of a speakers bureau for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare; Merck & Co., Inc.
    Received grants for clinical research from: Actelion Pharmaceuticals, Ltd; Bayer HealthCare; Merck & Co., Inc.

  • Oksana A. Shlobin, MD

    As listed above

Editor

  • George Boutsalis, PhD

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: George Boutsalis, PhD, has disclosed no relevant financial relationships.

  • Asha P. Gupta, PharmD, RPh

    Senior Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Asha P. Gupta, PharmD, RPh has disclosed no relevant financial relationships.

CME Reviewer

  • Robert Morris, PharmD

    Disclosures

    Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ViiV Healthcare
    Owns stock, stock options, or bonds from: GlaxoSmithKline

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories

 


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

New Concepts in PAH: Treating to Achieve Low-Risk Status

Authors: Sonja D. Bartolome, MD; Oksana A. Shlobin, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC Released: 3/31/2020

Valid for credit through: 3/31/2021

processing....

  • Print